October 5, 2016
VeriStrat® Test identifies patients with squamous cell carcinoma of the lung who are more likely to have improved survival on Afatinib therapy.
A leading data-driven diagnostic solutions company helping answer critical clinical questions faced by physicians, researchers, and biopharmaceutical companies, with a primary focus in lung disease.
2970 Wilderness Place, Suite 100 Boulder, CO 80301
© Copyright 2021 Biodesix. All Rights Reserved.